DAVE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DAVE is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The stock has strong momentum and bullish analyst support, but it is already extended and overbought, making this a poor immediate buy despite the constructive long-term growth story. I would not buy it at this price; I would wait for a pullback.
Price is in a strong uptrend with SMA_5 > SMA_20 > SMA_200 and MACD histogram positive and expanding, which confirms bullish momentum. However, RSI_6 at 89.651 is extremely overbought, suggesting the stock is stretched short-term. The current price at 386.225 is just below R1 at 390.514 and far above the pivot at 344.697, so upside from here looks limited unless it breaks resistance cleanly. Short-term pattern data also points to weakness over the next day and week before better medium-term performance.
Analysts remain broadly bullish, with multiple Buy/Outperform ratings and rising price targets. The latest and strongest update came from Benchmark, which raised its target to $475 from $345 and kept a Buy rating, citing continued momentum and the upcoming Flex Pay-in-4 card in 2027 as a further growth driver. Earlier notes also highlighted strong member growth, ARPU expansion, improving credit performance, product innovation, and potential re-rating. There is no negative news flow in the past week.
The stock is technically overbought and extended after a large year-to-date run. Insider activity is a clear negative, with insiders selling and the selling amount up 7151.84% over the last month. Hedge funds are neutral, so there is no strong institutional accumulation signal. No recent news catalyst was provided, and there is no recent congress trading data. The short-term pattern estimate also suggests possible near-term downside.
No usable latest-quarter financial snapshot was provided due to an error, so a full quarter-by-quarter assessment cannot be made. Based on analyst commentary, the latest quarter was described as a strong beat-and-raise type report with durable user growth, ARPU expansion, improved monetization, stronger credit control, and rising profitability. The latest quarter season referenced in the analyst notes is Q1 2026.
Analyst sentiment is clearly positive and has been trending upward. Recent updates included Benchmark raising its price target to $475 and maintaining Buy, Barrington raising to $310 and keeping Outperform, B. Riley raising to $370 and keeping Buy, UBS initiating at Buy with $300, and several other firms lifting targets into the $330-$365 range. The pros view DAVE as a durable growth fintech with strong execution, member expansion, and product innovation. The main con from the Street is valuation and whether the market has already priced in much of the growth, with Evercore taking a more neutral In Line view at $260.
